4//SEC Filing
Collins Cynthia 4
Accession 0000950170-23-028609
CIK 0001661460other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:10 PM ET
Size
7.0 KB
Accession
0000950170-23-028609
Insider Transaction Report
Form 4
Collins Cynthia
Director
Transactions
- Award
Common Stock
2023-06-15+19,650→ 39,300 total - Award
Stock Option (Right to buy)
2023-06-15+27,350→ 27,350 totalExercise: $2.47Exp: 2033-06-14→ Common Stock (27,350 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
- [F2]The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001405692
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:10 PM ET
- Size
- 7.0 KB